Article
Computational Druggability Assessment of Mitochondrial Targets: Structure-Function Constraints and Binding Site Characterization
2026-04-07
Abstract excerpt
<title>Abstract</title> <p>Background Precision drug design for mitochondrial disease requires a systematic evaluation of whether each drug target possesses a pharmacologically tractable binding site. Druggability is determined by the intersection of structural accessibility, ligand efficiency evidence, pharmacological precedent, and mitochondrial delivery feasibility. No comprehensive druggability map exists fo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3d2400ee-90ae-5b8b-b738-b53cdb9dab20
- DOI
- 10.21203/rs.3.rs-9305508/v1
